MDNC Medinotec Inc.
Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1931055 · Fiscal year ends 02/28
Financial factors as of 2026-08-31 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-10.9%
TTM net income YoY-73.4%
TTM EPS YoY-73.4%
Revenue 3-yr CAGR92.4%
Net income 3-yr CAGR—
Margins
Gross margin49.6%
Operating margin6.6%
Net margin5.8%
FCF margin—
EBITDA margin7.6%
Returns
ROE11.1%
ROA9.0%
ROIC (approx.)22.6%
Asset turnover1.53x
Leverage & solvency
Liabilities / assets14.7%
Debt / equity0.00x
Current ratio6.74x
Interest coverage21.76x
Cash quality & payout
Operating cash flow / net income0.63x
Accruals ratio3.3%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-02-28 | FY20252025-02-28 | FY20242024-02-29 | FY20232023-02-28 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $9.73M | $9.11M | $5.02M | $999,579 |
| Cost of revenue | $4.60M | $4.30M | -$2.58M | -$417,757 |
| Gross profit | $5.13M | $4.82M | $2.44M | $581,822 |
| R&D expense | $149,858 | $91,133 | -$22,351 | -$64,866 |
| SG&A expense | $2.32M | $1.35M | -$1.67M | -$648,172 |
| Operating income | $1.09M | $3.19M | $600,578 | -$238,587 |
| Interest expense | $87,595 | $176,416 | -$277,230 | -$226,814 |
| Pretax income | $1.07M | $3.02M | -$253,770 | -$391,477 |
| Income tax | -$274,685 | -$864,665 | -$150,918 | $38,742 |
| Net income | $794,502 | $2.16M | -$404,688 | -$352,735 |
| EBITDA | $1.18M | $3.27M | $688,803 | -$185,034 |
| EPS (basic) | 0.07 | 0.18 | -0.03 | -0.03 |
| EPS (diluted) | — | — | — | — |
| Banking | ||||
| Loans, net | — | — | — | $605,130 |
| Balance sheet | ||||
| Cash & equivalents | $2.76M | $2.77M | $2.81M | $2.83M |
| Receivables | $2.35M | $2.61M | $589,761 | $21,074 |
| Inventory | $1.24M | $988,341 | $863,452 | $354,304 |
| Current assets | $6.42M | $6.42M | $4.38M | $3.37M |
| PP&E, net | $331,346 | $348,486 | $320,122 | $406,873 |
| Total assets | $6.81M | $6.81M | $4.80M | $4.49M |
| Current liabilities | $1.10M | $1.51M | $827,453 | $71,311 |
| Total liabilities | $1.10M | $2.54M | $2.64M | $1.93M |
| Shareholders' equity | $5.71M | $4.27M | $2.17M | $2.56M |
| Shares outstanding | 11.76M | 11.73M | 11.73M | 11,734 |
| Cash flow statement | ||||
| Operating cash flow | $906,798 | $877,834 | $14,242 | -$490,549 |
| Capital expenditure | $1,363 | $89,013 | -$2,255 | $55,277 |
| Free cash flow | $905,435 | $788,821 | $16,497 | -$545,826 |
| Investing cash flow | -$1,363 | -$89,013 | $10,125 | -$529,723 |
| Financing cash flow | -$982,973 | -$894,482 | -$8,092 | $3.58M |
| Depreciation & amortization | $80,873 | $73,846 | $88,225 | $53,553 |
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.